MDB Capital Holdings, LLC (NASDAQ:MDBH) Sees Significant Decrease in Short Interest

MDB Capital Holdings, LLC (NASDAQ:MDBH) was the recipient of a large decrease in short interest in the month of July. As of July 31st, there was short interest totaling 848 shares, a decrease of 73.2% from the July 15th total of 3,170 shares. Based on an average daily volume of 1,392 shares, the short-interest ratio is currently 0.6 days. Approximately 0.0% of the shares of the company are short sold.

MDB Capital Stock Down 2.3%

Shares of MDBH stock traded down $0.07 during mid-day trading on Thursday, reaching $2.96. The stock had a trading volume of 199 shares, compared to its average volume of 5,351. The firm’s 50 day simple moving average is $3.12 and its 200 day simple moving average is $3.26. MDB Capital has a one year low of $2.45 and a one year high of $4.80. The firm has a market cap of $30.49 million, a PE ratio of -1.40 and a beta of 1.21.

MDB Capital (NASDAQ:MDBH) last released its quarterly earnings data on Thursday, May 14th. The company reported ($0.65) earnings per share (EPS) for the quarter.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of MDB Capital in a report on Thursday, July 2nd. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has a consensus rating of “Sell”.

Institutional Investors Weigh In On MDB Capital

Institutional investors have recently bought and sold shares of the business. Raymond James Financial Inc. acquired a new position in shares of MDB Capital in the 2nd quarter valued at $27,000. DRW Securities LLC acquired a new stake in shares of MDB Capital during the 4th quarter valued at about $40,000. Finally, Citadel Advisors LLC acquired a new stake in shares of MDB Capital during the 3rd quarter valued at about $43,000. Institutional investors and hedge funds own 0.35% of the company’s stock.

About MDB Capital

MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business.